Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Membrane progesterone receptor gamma (mPRγ), also known as PAQR5, is a member of the membrane progesterone receptor (mPR) family, which are part of the progestin and adipoQ receptor (PAQR) superfamily. These receptors mediate rapid, non-genomic actions of progesterone at the cell membrane, distinct from classical nuclear progesterone receptors. Upon ligand binding, mPRγ activates intracellular signaling pathways via coupling to G proteins—specifically through Gi-mediated pathways that can inhibit cAMP production and modulate other second messenger systems. mPRγ and other mPR subtypes mediate various reproductive functions such as oocyte maturation in teleost fishes and possibly mammals; they may also play roles in immune modulation and neuroprotection by mediating fast responses to progestogens at or near the plasma membrane rather than through gene transcription regulation.
Agonist; binds to mPRγ and activates intracellular signaling pathways via coupling to G proteins, specifically Gi-mediated pathways that can inhibit cAMP production.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane Progesterone Receptor Gamma (mPRγ).